CD274 and cancer: Checkpoint inhibitors, such as PDL1 inhibitors, are used for treatment of numerous cancers (Gato-Cañas et al., 2017), and there are many ongoing trials focusing on the identification of novel biomarkers in gliomas (Saadatpour et al., 2016).